上海科技大学知识管理系统

Disclosed are uses of NAD+ and//or NAD+ agonists and//or NAD+ inhibitors for preparing a preparation or a kit, and a combination preparation including T cells and NAD+ and//or NAD+ agonists and//or NAD+ inhibitors. The preparation or kit is used for regulating T cell activity, regulating the expression level of CD69 on the surface of T cells, and//or regulating the phosphorylation level in T cells, and//or treating diseases related to T cell activity.

公开了NAD+和//或NAD+激动剂和//或NAD+抑制剂用于制备制剂或试剂盒以及包括T细胞和NAD+和//或NAD+激动剂和//或NAD+抑制剂的组合制剂的用途。 所述制剂或试剂盒用于调节T细胞活性，调节T细胞表面CD69的表达水平，和//或调节T细胞内磷酸化水平，和//或治疗与T细胞活性相关的疾病。